IMA Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
17.3M
+46.9%
11.8M
-2.4%
12.1M
+42.0%
8.5M
-67.5%
26.2M
R&D
11.3M
+69.0%
6.7M
+11.9%
6.0M
+82.1%
3.3M
-78.4%
15.2M
SG&A
6.0M
+18.1%
5.1M
-16.4%
6.1M
+17.0%
5.2M
-52.6%
11.0M
Operating Income
-17309000
-46.9%
-11784000
+2.4%
-12079000
-42.0%
-8504000
+67.5%
-26192000
EBITDA
-17309000
-46.9%
-11784000
+2.4%
-12079000
-48.9%
-8111000
+69.0%
-26190000
Net Income
-15620000
-53.5%
-10178000
+4.2%
-10619000
-53.7%
-6908000
+72.1%
-24779000
EPS (Basic)
$-0.91
-44.4%
$-0.63
+33.7%
$-0.95
+19.5%
$-1.18
+59.5%
$-2.91
EPS (Diluted)
$-0.91
-44.4%
$-0.63
+33.7%
$-0.95
+19.5%
$-1.18
+59.5%
$-2.91
Shares (Diluted)
17.1M
+5.9%
16.2M
+44.2%
11.2M
+90.8%
5.9M
-33.2%
8.8M
ImageneBio (IMA) — Financials